🟦 Non-Member Event : The Coalition for Hemophilia B 2023 Annual Hybrid Symposium
Date: March 16th - 19th (Orlando, FL & Virtual) Click here for info.
All members have the option of attending our various HTC-centric events which include:
Date: March 16th - 19th (Orlando, FL & Virtual) Click here for info.
Date: March 27th - 29th (San Diego, CA) Click here for info.
Date: Wednesday, April 5, 2023 Time: 1:00pm - 2:00pm ET Click here to register
Date: April 13th - 16th (Orlando, FL) Click here for info.
Date: Monday, April 17, 2023 Time: 1:00pm - 2:00pm ET Click here to register
Date: April 26th - 29th Location: San Mateo, California Venue: San Mateo Marriott San Francisco Airport Please contact Jeff Amond with any questions regarding this registration at amond@hemoalliance.org or 608-206-3132.
Location: New York City, NY Please confirm that you can commit to attend the entire meeting before registering. If you have questions regarding this registration please contact Sean Singh at sean@hemoalliance.org / 813-748-7226 or Theresa Parker at theresa@hemoalliance.org / 727-688-2568.
Date: May 10th - 12th (Buenos Aires, Argentina) Click here for info.
Location: Washington, DC Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727.688.2568.
Date: Thursday, June 15, 2023 Time: 1:30pm - 2:30pm ET TOPIC: Discover ALTUVIIIO™, A New Treatment Option for Your Patients, and the Customized Support Services Designed to Assist You OBJECTIVES: Provide background and education on the science behind ALTUVIIIO™ and how to apply it to your clinical practice Understand the roles and resources that Sanofi’s Read the full article...
Date: June 16th - 18th (San Antonio, TX) Click here for info.
Date: June 24th - 28th (Montreal, Canada) Click here for info.
Date: Thursday, June 29, 2023 Time: 2:00pm - 3:00pm ET TOPIC: Value Based Agreements with Payers OBJECTIVES: Takeda is excited to share more information about the transition from transactional relationships with payers to value based agreements in a real world example. Mark will provide an overview of how these agreements work, the metrics used, and Read the full article...
Date: July 10th - 12th (Washington, DC) Click here for info.
Date: Thursday, July 13, 2023 Time: 2:00pm - 3:00pm ET TOPIC: Gene Therapy Update OBJECTIVES: Review the status of Roctavian and Hemgenix, gene therapy products and the Alliance contracts with the Biomarin and CSL. Provide information on how to obtain the products and ensure they are infusion ready. Examine the rationale behind Biomarin's decision to use Read the full article...
Date: Tuesday, August 8, 2023 Time: 1:00pm - 2:00pm ET TITLE: HTC preparation for ROCTAVIAN ™ (valoctocogene roxaparvovec-rvox) OBJECTIVE: Learn about eligibility testing, ordering, storing, handling and administering ROCTAVIAN TARGET AUDIENCE: HTC staff interested in learning about ROCTAVIAN’s clinical and logistical requirements SPEAKER: Henry Mead PhD, MBA, MPA Senior Director, BioMarin Hemophilia North America Medical Read the full article...
Date: August 17th - 19th (National Harbor, MD) Click here for info.
Date: Tuesday, August 22, 2023 Time: 2:00pm - 3:00pm ET The webinar will review how to stay compliant with USP 797 SOP’s Training Competencies Task Management Reporting Alerting Elimination of Blind Spots Please contact Mark Plencner at mark@hemoalliance.org with questions.
Date: September 18th - 22nd Click here for info.
Date: Wednesday, September 20, 2023 Time: 1:00pm - 2:00pm ET TITLE: Case Discussion: Adult Severe Type 3 von Willebrand Disease Patient OBJECTIVE: In case you missed it at the National Bleeding Disorders Foundation conference, join expert Dr. Jonathan Roberts, MD for an interactive discussion about managing patients who are living with von Willebrand Disease (VWD). Read the full article...